- Home
- SPCB vs ALGS Comparison
SPCB vs ALGS Comparison
Compare SPCB & ALGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPCB
- ALGS
- Stock Information
- Founded
- SPCB 1988
- ALGS 2018
- Country
- SPCB Israel
- ALGS United States
- Employees
- SPCB N/A
- ALGS N/A
- Industry
- SPCB Semiconductors
- ALGS Biotechnology: Pharmaceutical Preparations
- Sector
- SPCB Technology
- ALGS Health Care
- Exchange
- SPCB Nasdaq
- ALGS Nasdaq
- Market Cap
- SPCB 53.3M
- ALGS 53.0M
- IPO Year
- SPCB N/A
- ALGS 2020
- Fundamental
- Price
- SPCB $9.23
- ALGS $8.17
- Analyst Decision
- SPCB Strong Buy
- ALGS Strong Buy
- Analyst Count
- SPCB 1
- ALGS 1
- Target Price
- SPCB $18.00
- ALGS $70.00
- AVG Volume (30 Days)
- SPCB 98.6K
- ALGS 82.0K
- Earning Date
- SPCB 08-14-2025
- ALGS 08-05-2025
- Dividend Yield
- SPCB N/A
- ALGS N/A
- EPS Growth
- SPCB N/A
- ALGS N/A
- EPS
- SPCB 1.89
- ALGS N/A
- Revenue
- SPCB $27,831,000.00
- ALGS $3,270,000.00
- Revenue This Year
- SPCB $2.73
- ALGS N/A
- Revenue Next Year
- SPCB $22.87
- ALGS $51.55
- P/E Ratio
- SPCB $4.76
- ALGS N/A
- Revenue Growth
- SPCB 2.90
- ALGS N/A
- 52 Week Low
- SPCB $2.55
- ALGS $3.76
- 52 Week High
- SPCB $18.95
- ALGS $46.80
- Technical
- Relative Strength Index (RSI)
- SPCB 42.82
- ALGS 49.11
- Support Level
- SPCB $9.00
- ALGS $7.70
- Resistance Level
- SPCB $9.59
- ALGS $9.25
- Average True Range (ATR)
- SPCB 0.48
- ALGS 0.69
- MACD
- SPCB -0.10
- ALGS -0.16
- Stochastic Oscillator
- SPCB 14.40
- ALGS 21.17
About SPCB SuperCom Ltd. (Israel)
SuperCom Ltd is an Israel-based provider of traditional and digital identity solutions, providing safety, identification, tracking, and security products to governments and organizations. The company comprises three main Strategic Business Units: e-Gov; IoT, which is the key revenue driver; and Cyber Security. The Company's IoT products and solutions reliably identify, track and monitor people or objects in real time, enabling the customers to detect unauthorized movement of people, vehicles and other monitored objects. The geographical segments of the company include Africa, European countries, South America, the United States, Israel, and APAC.
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.